Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xianjun Yu

Showing results (161-170 of 421) with videos related to

Pageof 43
Sort By:
International Journal of Molecular Sciences|April 20, 2016
Up-Regulation of PAI-1 and Down-Regulation of uPA Are Involved in Suppression of Invasiveness and Motility of Hepatocellular Carcinoma Cells by a Natural Compound BerberineXuanbin Wang, Ning Wang, Hongliang Li, et al.
Cellular and Molecular Life Sciences : CMLS|October 11, 2017
Do anti-stroma therapies improve extrinsic resistance to increase the efficacy of gemcitabine in pancreatic cancer?Chen Liang, Si Shi, Qingcai Meng, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 24, 2016
Roux-en-Y pancreaticojejunostomy reconstruction after deep enucleation of benign or borderline pancreatic lesions: a single-institution experienceZhiwen Xiao, Guopei Luo, Zuqiang Liu, et al.
International Journal of Cancer|July 7, 2018
MiR-29a, targeting caveolin 2 expression, is responsible for limitation of pancreatic cancer metastasis in patients with normal level of serum CA125Chen Liang, Si Shi, Qingcai Meng, et al.
Journal of Hematology & Oncology|November 20, 2020
The promising role of noncoding RNAs in cancer-associated fibroblasts: an overview of current status and future perspectivesZengli Fang, Jin Xu, Bo Zhang, et al.
Gut|January 6, 2026
Integrated screens reveal that guanine nucleotide depletion, which is irreversible via targeting IMPDH2, inhibits pancreatic cancer and potentiates KRAS inhibitionDi Wu, Chunbin Zhu, Haoqi Pan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 24, 2025
A pilot study of nectin-4-targeted radioligand [<sup>68</sup>Ga]Ga-FZNR-1 in patients with pancreatic ductal adenocarcinoma: head-to-head comparison with [<sup>18</sup>F]-FDGChunjuan Jiang, Miaoyan Wei, Panli Li, et al.
Chinese Medical Journal|August 11, 2025
SMUG1 promotes the progression of pancreatic cancer via AKT signaling pathway through binding with FOXQ1Zijian Wu, Wei Wang, Jie Hua, et al.
Journal of Gastrointestinal Oncology|July 11, 2024
Identification of pancreatic adenocarcinoma immune subtype associated with tumor neoantigen from aberrant alternative splicingQiong Du, Zhan Yu, Zifeng Zhang, et al.
Experimental & Molecular Medicine|August 31, 2023
Functional significance of cholesterol metabolism in cancer: from threat to treatmentMingming Xiao, Jin Xu, Wei Wang, et al.
Pageof 43

Showing results (161-170 of 421) with videos related to

Sort By:
Pageof 43
International Journal of Molecular Sciences|April 20, 2016
Up-Regulation of PAI-1 and Down-Regulation of uPA Are Involved in Suppression of Invasiveness and Motility of Hepatocellular Carcinoma Cells by a Natural Compound BerberineXuanbin Wang, Ning Wang, Hongliang Li, et al.
Cellular and Molecular Life Sciences : CMLS|October 11, 2017
Do anti-stroma therapies improve extrinsic resistance to increase the efficacy of gemcitabine in pancreatic cancer?Chen Liang, Si Shi, Qingcai Meng, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 24, 2016
Roux-en-Y pancreaticojejunostomy reconstruction after deep enucleation of benign or borderline pancreatic lesions: a single-institution experienceZhiwen Xiao, Guopei Luo, Zuqiang Liu, et al.
International Journal of Cancer|July 7, 2018
MiR-29a, targeting caveolin 2 expression, is responsible for limitation of pancreatic cancer metastasis in patients with normal level of serum CA125Chen Liang, Si Shi, Qingcai Meng, et al.
Journal of Hematology & Oncology|November 20, 2020
The promising role of noncoding RNAs in cancer-associated fibroblasts: an overview of current status and future perspectivesZengli Fang, Jin Xu, Bo Zhang, et al.
Gut|January 6, 2026
Integrated screens reveal that guanine nucleotide depletion, which is irreversible via targeting IMPDH2, inhibits pancreatic cancer and potentiates KRAS inhibitionDi Wu, Chunbin Zhu, Haoqi Pan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 24, 2025
A pilot study of nectin-4-targeted radioligand [<sup>68</sup>Ga]Ga-FZNR-1 in patients with pancreatic ductal adenocarcinoma: head-to-head comparison with [<sup>18</sup>F]-FDGChunjuan Jiang, Miaoyan Wei, Panli Li, et al.
Chinese Medical Journal|August 11, 2025
SMUG1 promotes the progression of pancreatic cancer via AKT signaling pathway through binding with FOXQ1Zijian Wu, Wei Wang, Jie Hua, et al.
Journal of Gastrointestinal Oncology|July 11, 2024
Identification of pancreatic adenocarcinoma immune subtype associated with tumor neoantigen from aberrant alternative splicingQiong Du, Zhan Yu, Zifeng Zhang, et al.
Experimental & Molecular Medicine|August 31, 2023
Functional significance of cholesterol metabolism in cancer: from threat to treatmentMingming Xiao, Jin Xu, Wei Wang, et al.
Pageof 43